Related Experiment Video
Updated: Mar 22, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Predictors and moderators of treatment outcomes from cognitive behavioural interventions for insomnia in adults: A
Monique L Smith1, Erin Oldenhof2, Jamie Byrne1
1School of Psychology, Deakin University, Burwood, Australia.
Abstract:
Insomnia is a heterogeneous disorder, for which cognitive behavioural therapy for insomnia (CBT-I) is the recommended first-line treatment. However, CBT-I is not effective for all patients. It is important to identify pre-treatment predictors and moderators of treatment-response to CBT-I and its variants to guide precision insomnia management approaches. This systematic review (PROSPERO: CRD42023476013) aimed to synthesise evidence on pre-treatment characteristics that predict or moderate insomnia outcomes following CBT-I. Peer-reviewed papers that reported such analyses from randomised and non-randomised studies of adults with insomnia were eligible. Four databases and citations of included reports were searched until April 2025. From 7325 unique records, 1494 full-text records were screened, of which 103 reports were included. Among 195 unique predictors/moderators identified from 1208 results, 92.3% were infrequently studied and/or rarely demonstrated statistical significance as predictors of insomnia improvement. The most consistent predictors of improvement included shorter insomnia duration, more severe insomnia, longer objective sleep duration, positive attitudes towards treatment, lower depression severity, and the absence of comorbid mental disorders, fatigue and pain. Further high-quality research using sufficiently powered samples and theoretically-justified moderators is needed to establish characteristics related to differential outcomes between cognitive behavioural interventions.
More Related Videos
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
Related Concept Videos
Insomnia
Multiple factors contribute...
Management of Insomnia
Blind Procedures
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...